Is PHGUF or NOBL a better dividend investment in 2026?

PHGUF currently yields 132.45% with a 5% 5-year dividend growth rate. NOBL yields 4.00% with 5% growth. The better choice depends on your goal: PHGUF offers higher current income.

What is the dividend yield difference between PHGUF and NOBL?

PHGUF has a forward dividend yield of 132.45% ($2.00/share annually). NOBL yields 4.00% ($2.00/share annually). The yield gap is 128.45 percentage points.

Home › Compare › PHGUF vs NOBL

PHGUF vs NOBL: Dividend Comparison 2026

PHGUF yields 132.45% · NOBL yields 4.00%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 PHGUF wins by $13.50M in total portfolio value

INVESTMENT

TIME HORIZON10 years

PHGUF

● Live price

132.45%

Share price

$1.51

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$13.53M

Annual income

$5,443,687.21

Full PHGUF calculator →

NOBL

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$28.0K

Annual income

$899.19

Full NOBL calculator →

Portfolio growth — PHGUF vs NOBL

📍 PHGUF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	PHGUF	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, PHGUF + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

PHGUF pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PHGUF

Annual income on $10K today (after 15% tax)

$11,258.28/yr

After 10yr DRIP, annual income (after tax)

$4,627,134.13/yr

NOBL

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$764.31/yr

At 15% tax rate, PHGUF beats the other by $4,626,369.82/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PHGUF + NOBL for your $10,000?

PHGUF: 50%NOBL: 50%

100% NOBL50/50100% PHGUF

Portfolio after 10yr

$6.78M

Annual income

$2,722,293.21/yr

Blended yield

40.16%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on PHGUF right now

PHGUF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

51.7

Piotroski

6/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PHGUF buys

NOBL buys

No recent congressional trades found for PHGUF or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricPHGUFNOBL

Forward yield	132.45% ✓	4.00%
Annual dividend / share	$2.00	$2.00
Payout ratio	50%	50%
1-year div growth	0%	5% ✓
5-year div CAGR	0%	5% ✓
Portfolio after 10y	$13.53M	$28.0K ✓
Annual income after 10y	$5,443,687.21 ✓	$899.19
Total dividends collected	$12.40M ✓	$6.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: PHGUF vs NOBL ($10,000, DRIP)

Year	PHGUF Portfolio	PHGUF Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$23,945	$13,245.03	$11,120	$420.00	+$12.8K → PHGUF
2	$55,262	$29,640.44	$12,357	$458.31	+$42.9K → PHGUF
3	$123,061	$63,930.66	$13,721	$499.76	+$109.3K → PHGUF
4	$264,727	$133,051.80	$15,227	$544.58	+$249.5K → PHGUF
5	$550,752	$267,494.95	$16,885	$593.02	+$533.9K → PHGUF
6	$1,109,410	$520,104.50	$18,713	$645.34	+$1.09M → PHGUF
7	$2,166,203	$979,134.42	$20,724	$701.81	+$2.15M → PHGUF
8	$4,104,595	$1,786,757.87	$22,938	$762.73	+$4.08M → PHGUF
9	$7,556,038	$3,164,121.24	$25,372	$828.41	+$7.53M → PHGUF
10	$13,528,648	$5,443,687.21	$28,047	$899.19	+$13.50M → PHGUF

PHGUF vs NOBL: Complete Analysis 2026

PHGUF — Stock

Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre-eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of hereditary angioedema. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Full PHGUF Calculator →

NOBL — ETF

NOBL is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in NOBL shares.

Full NOBL Calculator →

📬

Get this PHGUF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PHGUF vs SCHD PHGUF vs JEPI PHGUF vs O PHGUF vs KO PHGUF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.